Valeant rejected takeover bid from Takeda, TPG: report

Valeant Pharmaceuticals International Inc. received a joint takeover approach this spring from Japan’s Takeda Pharmaceutical Co. and private-equity firm TPG that the beleaguered drug maker rejected, according to people familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.